NCT00779519View on ClinicalTrials.gov

Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

December 31, 2009

Conditions

Obesity

Interventions

DRUG

TTP435

DRUG

Placebo

Trial Locations (12)

10065

New York

23294

Richmond

23502

Norfolk

26704

Springfield

28277

Charlotte

30909

Augusta

89502

Reno

90095

Los Angeles

92130

San Diego

B3K 5R3

Halifax

L6H 3P1

Oakville

Unknown

Toronto

Sponsors

Lead Sponsor

vTv Therapeutics

All Listed Sponsors

lead

vTv Therapeutics

INDUSTRY

NCT00779519 - Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss | Biotech Hunter | Biotech Hunter